| 2026-04-29T06:51:33.117170+00:00 |
audit_add_remaining_culturebotht
|
CREATED_AS_UNMAPPED |
UNMAPPED
|
Imported from CultureBotHT (compounds_to_cas.csv (no CAS-RN)). No CAS-RN or CHEBI mapping available; curator review needed. |
| 2026-05-11T08:12:15Z |
mediaingredientmech-agentic-curation
LLM
|
REVIEWED_COBAMIDE_VARIANT |
UNMAPPED
|
Classified as a single cobamide-family ingredient and left unmapped because no exact local ontology identity for the 5-methylbenzimidazolyl lower-ligand variant was verified. |
| 2026-06-17T00:00:00+00:00 |
deep-research-ingredient-edison
LLM
|
RESEARCHED_IDENTITY |
UNMAPPED
|
Edison/PaperQA3 deep research: discrete cobamide variant (lower ligand = 5-methylbenzimidazole; "5-MeBza-Cba"); no stable CHEBI/CAS, and mapping to cobalamin would be chemically incorrect at the lower-ligand level. Kept UNMAPPED. |
| 2026-08-06T00:00:00+00:00 |
edison_literature_identity
LLM
|
ANNOTATED |
|
Edison LITERATURE (PaperQA3) identity research; report at research/ingredients/5-methylbenzimidazolyl_Cobamide-edison-literature.md (local artifact — research/ is gitignored, so the findings are quoted here rather than linked). Report verdict: ## Executive recommendation — Retain **`UNMAPPED`**. The label denotes a chemically meaningful, discrete cobamide variant defined by a **5-methylbenzimidazole lower ligand**, but it does not specify the variable upper axial ligand. No exact stable ontology CURIE, CAS Registry Number, or unique source-backed formula was verified. Therefore, create **no SSSOM identity row** at present. In particular No ontology CURIE was proposed. Recorded as provenance only — no grounding applied from this run. Edison's recommendations are deliberately conservative, and a plausible identifier promoted by a mechanism that never decided anything is what #203 and #263 exist to undo. Any CURIE above is a curator's to accept or reject. |